Mоlimо vаs kоristitе оvај idеntifikаtоr zа citirаnjе ili оvај link dо оvе stаvkе:
https://open.uns.ac.rs/handle/123456789/2901
Nаziv: | Application of a widely-used tropical anti-worm agent, mebendazole, in modern oncology | Аutоri: | Dušica Popović Mihalj Poša Kosta Popović Jovanka Kolarović Jovan Popović Pavle Banović |
Ključnе rеči: | Anthelmintic;Mebendazole;Cancer treatment;Antimicrotubullar effect;Antineoangiogenesis | Dаtum izdаvаnjа: | 1-окт-2017 | Čаsоpis: | Tropical Journal of Pharmaceutical Research | Sažetak: | © Pharmacotherapy Group. Although clinical trials have not been completed, it has already been confirmed that mebendazole, a well-known anti-parasitic drug widely used in the tropical areas, inhibits cancer cell growth. Preclinical studies show that mebendazole notably impedes the growth of malignant and metastatic tumors such as osteosarcoma and soft tissue sarcoma, melanoma, carcinoma (lung, colorectal, breast, ovarian, hepatocellular and adrenocortical), acute myeloid leukaemia, glioblastoma multiforme and meduloblastoma. Mebendazole can induce the depolymerization of microtubules in neoplasms and newly formed vasculature, stopping tumor growth and neoangiogenesis, along with other proposed mechanisms of action. | URI: | https://open.uns.ac.rs/handle/123456789/2901 | ISSN: | 1596-5996 | DOI: | 10.4314/tjpr.v16i10.32 |
Nаlаzi sе u kоlеkciјаmа: | MDF Publikacije/Publications |
Prikаzаti cеlоkupаn zаpis stаvki
SCOPUSTM
Nаvоđеnjа
6
prоvеrеnо 03.05.2024.
Prеglеd/i stаnicа
37
Prоtеklа nеdеljа
11
11
Prоtеkli mеsеc
4
4
prоvеrеnо 10.05.2024.
Google ScholarTM
Prоvеritе
Аlt mеtrikа
Stаvkе nа DSpace-u su zаštićеnе аutоrskim prаvimа, sа svim prаvimа zаdržаnim, оsim аkо nije drugačije naznačeno.